CEPI (Coalition for Epidemic Preparedness Innovations)

CEPI (Coalition for Epidemic Preparedness Innovations) is dedicated to pioneering advancements in research services, with a focus on developing new vaccines for a safer world. Operating as an innovative partnership between public, private, philanthropic, and civil organizations, CEPI was launched in Davos in 2017 with the mission to accelerate the development of vaccines and other biologic countermeasures against epidemic and pandemic threats. CEPI ensures that these vital resources are accessible to all people in need. CEPI is located at Skøyen Atrium, Askekroken 11, Oslo, 0277, NO; 215 Euston Road, London, England, GB; and 1901 Pennsylvania Ave NW, Washington, District of Columbia 20006, US.



CEPI’s commitment extends to making significant scientific progress to respond to the next Disease X threat effectively. The CEPI 2.0 plan for 2022-2026 aims to create a new vaccine in just 100 days, which is also known as the 100 Days Mission. CEPI continues to work tirelessly to enhance global health security through cutting-edge research and collaborative initiatives.



CEPI is proactive in fostering global health and safety through comprehensive vaccine development and preparedness strategies. We invite the management team to create a customized and exclusive company showcase and product listing on our platform. This will provide an enhanced avenue to connect with partners and stakeholders, further amplifying CEPI’s impact on global epidemic preparedness.